Market Cap

Polyphor AG Market Capitalization:

CHF19.3 Million

CHF as of Dec. 1, 2021

US$21.0 Million

business Polyphor AG Company Profile

Polyphor AG Main Stock Listing

SIX: POLN

Market Capitalization History of Polyphor AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Polyphor AG market cap

Date Market Cap YoY Change
Jan. 1, 2021 CHF89.2 M 12.05%
Jan. 1, 2020 CHF79.6 M -69.10%
Jan. 1, 2019 CHF257.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Polyphor AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

Polyphor AG has the following listings and related stock indices.


Stock: SIX: POLN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.